Lung cancer Natural History, Complications and Prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 4: Line 4:


==Overview==
==Overview==
The majority of lung cancers present with advanced disease because the [[symptoms]] tend to occur later in the course of the disease. The patient experiences non-specific symptoms such as [[cough]], [[hemoptysis]], [[dyspnea]], [[chest pain]], [[dysphonia]], [[dysphagia]], [[fatigue]], [[lack of appetite]], [[weight loss]], and [[fatigue]] from 3 weeks to 3 months before seeking medical attention. There are a variety of complications associated with lung cancer such as [[pleural effusion]], leg weakness [[paresthesias]], bladder dysfunction, [[seizures]], [[hemiplegia]], [[cranial nerve palsies]], [[confusion]], [[personality changes]], skeletal pain, and/or [[pleuritic pain]], [[atelectasis]], and/or [[bronchopleural fistula]]. The [[prognosis]] of lung cancer is poor if diagnosed during the advanced stages.
The majority of lung cancers present with advanced [[disease]] because the [[symptoms]] tend to occur later in the course of the [[disease]]. [[Patient|Patients]] experience non-specific [[Symptom|symptoms]] such as [[cough]], [[hemoptysis]], [[dyspnea]], [[chest pain]], [[dysphonia|difficulty speaking]], [[dysphagia|difficulty swallowing]], [[lack of appetite]], [[weight loss]], and [[fatigue]] from 3 weeks to 3 months before seeking medical attention. There are a variety of [[complications]] associated with lung cancer, such as [[pleural effusion]], [[leg weakness]], [[paresthesias]], [[Urinary bladder|bladder]] dysfunction, [[seizures]], [[hemiplegia]], [[cranial nerve palsies]], [[confusion]], [[personality changes]], [[Skeleton|skeletal]] [[pain]], [[pleuritic pain]], [[atelectasis]], and [[bronchopleural fistula]]. The [[prognosis]] of lung cancer is poor if [[Diagnosis|diagnosed]] at the advanced stages.


==Natural History==
==Natural History, Complications, and Prognosis==
*The majority of lung cancers present with advanced disease because the [[symptoms]] tend to occur later in the course of the disease.<ref name="leary">{{cite book | last = Leary | first = A | title = Lung cancer a multidisciplinary approach | publisher = Wiley-Blackwell | location = Chichester, West Sussex, UK Ames, Iowa | year = 2012 | isbn = 9781405180757 }}</ref>
*The patient experiences non-specific [[symptoms]] such as [[cough]], [[hemoptysis]], [[dyspnea]], [[chest pain]], [[dysphonia]], [[dysphagia]], lack of appetite, [[weight loss]], and [[fatigue]] from 3 weeks to 3 months before seeking medical attention.
*While of duration of [[symptoms]], the [[tumor]] cell may double 20 times.<ref name="leary">{{cite book | last = Leary | first = A | title = Lung cancer a multidisciplinary approach | publisher = Wiley-Blackwell | location = Chichester, West Sussex, UK Ames, Iowa | year = 2012 | isbn = 9781405180757 }}</ref>
*In more advanced disease, the [[tumor]] may spread to other organs such as the [[spinal cord]], [[brain]], and [[bone]].
*These patients may develop [[symptoms]] such as leg weakness, [[paresthesias]], bladder dysfunction, [[seizures]], [[hemiplegia]], cranial nerve palsies, [[confusion]] , personality changes, skeletal pain, and [[pleuritic]] pain.<ref name="leary">{{cite book | last = Leary | first = A | title = Lung cancer a multidisciplinary approach | publisher = Wiley-Blackwell | location = Chichester, West Sussex, UK Ames, Iowa | year = 2012 | isbn = 9781405180757 }}</ref>
*Once the cancer spreads to the other organs, it is most likely fatal.


==Complications==
=== Natural History ===
 
*The majority of lung cancers present with advanced [[disease]] because the [[symptoms]] tend to occur later in the course of the [[disease]].<ref name="leary">{{cite book | last = Leary | first = A | title = Lung cancer a multidisciplinary approach | publisher = Wiley-Blackwell | location = Chichester, West Sussex, UK Ames, Iowa | year = 2012 | isbn = 9781405180757 }}</ref>
*[[Patient|Patients]] experience non-specific [[Symptom|symptoms]] such as [[cough]], [[hemoptysis]], [[dyspnea]], [[chest pain]], [[dysphonia|difficulty speaking]], [[dysphagia|difficulty swallowing]], [[lack of appetite]], [[weight loss]], and [[fatigue]] from 3 weeks to 3 months before seeking medical attention.
*Depending on the duration of the presence of [[symptoms]], the [[Tumor cell|tumor cells]] may double 20 times.<ref name="leary">{{cite book | last = Leary | first = A | title = Lung cancer a multidisciplinary approach | publisher = Wiley-Blackwell | location = Chichester, West Sussex, UK Ames, Iowa | year = 2012 | isbn = 9781405180757 }}</ref>
*In more advanced [[disease]], the [[tumor]] may spread to other [[Organ (anatomy)|organs]] such as the [[spinal cord]], [[brain]], and [[bone]].
*These [[Patient|patients]] may develop [[symptoms]] such as [[leg weakness]], [[paresthesias]], [[Urinary bladder|bladder]] dysfunction, [[seizures]], [[hemiplegia]], [[cranial nerve palsies]], [[confusion]], [[personality changes]], [[Skeleton|skeletal]] [[pain]], and [[pleuritic pain]].<ref name="leary">{{cite book | last = Leary | first = A | title = Lung cancer a multidisciplinary approach | publisher = Wiley-Blackwell | location = Chichester, West Sussex, UK Ames, Iowa | year = 2012 | isbn = 9781405180757 }}</ref>
*Once the [[cancer]] spreads to the other [[Organ (anatomy)|organs]], it is most likely [[fatal]].
 
===Complications===
'''General Complications'''
'''General Complications'''


The complications associated with Lung cancer are:<ref name="Jones">{{cite journal | last =Jones | first =DR | coauthors =Detterbeck FC | title =Pancoast tumors of the lung | journal =Current Opinion in Pulmonary Medicine | volume =4 | issue =4 | pages =191–197 | date =Jul 1998 | pmid =10813231 }}</ref><ref name="pmid16476534">{{cite journal |vauthors=Eren S, Karaman A, Okur A |title=The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT |journal=Eur J Radiol |volume=59 |issue=1 |pages=93–103 |year=2006 |pmid=16476534 |doi=10.1016/j.ejrad.2006.01.003 |url=}}</ref>
The [[Complication (medicine)|complications]] associated with lung cancer are:<ref name="Jones">{{cite journal | last =Jones | first =DR | coauthors =Detterbeck FC | title =Pancoast tumors of the lung | journal =Current Opinion in Pulmonary Medicine | volume =4 | issue =4 | pages =191–197 | date =Jul 1998 | pmid =10813231 }}</ref><ref name="pmid16476534">{{cite journal |vauthors=Eren S, Karaman A, Okur A |title=The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT |journal=Eur J Radiol |volume=59 |issue=1 |pages=93–103 |year=2006 |pmid=16476534 |doi=10.1016/j.ejrad.2006.01.003 |url=}}</ref>
* [[Breathing difficulties]]
* [[Breathing difficulties]]
:* Lung cancer patients can experience trouble breathing especially when [[tumors]] grow and block the airways. Also, it is possible for fluid to build up in the lungs of the patients which makes it difficult for the lungs to fully expand when [[inhaling]].
 
:* Lung cancer [[Patient|patients]] can experience trouble in [[breathing]] especially when [[tumors]] grow and block the [[Airway|airways]]. Also, it is possible for [[fluid]] to build up in the [[Lung|lungs]] of the [[Patient|patients]] which can negatively affect [[breathing]].
* [[Pneumonia]]
* [[Pneumonia]]
:* If the cancer grows in the [[airway]], it may obstruct airflow, causing [[dyspnea|breathing difficulties]]. This can lead to accumulation of secretions behind the blockage, predisposing the patient to [[pneumonia]].
 
* [[Hemoptysis]] (coughing up blood)
:* If the [[cancer]] grows in the [[airway]], it may obstruct airflow, causing [[dyspnea|breathing difficulties]]. This can lead to accumulation of [[Secretion|secretions]] behind the blockage, predisposing the [[patient]] to [[pneumonia]].
:* Occasionally lung cancer can cause bleeding in the airways which results in the patient coughing up [[blood]].
* [[Hemoptysis]]  
 
:* Occasionally, lung cancer can cause [[bleeding]] in the [[Airway|airways]] which can result in [[hemoptysis]].
* [[Pain]]
* [[Pain]]
:* It is possible that lung cancer will cause pain as well, especially if it spreads to the lining of the lung, or other areas of the body, like the [[bones]].
 
:* There are treatments to help combat the pain.
:* It is possible that lung cancer will cause [[pain]] as well, especially if it spreads to the [[pleura]] or other areas of the [[Human body|body]], like the [[bones]].
 
* [[Pleural effusion]]
* [[Pleural effusion]]
:* Lung cancer can cause fluid to build up in the lungs which can cause breathing difficulties.
 
:* There are treatments available to help drain the excess fluid
:* Lung cancer can cause [[fluid]] to build up in the [[Lung|lungs]] which can cause [[breathing]] difficulties.
 
* [[Metastasis]]
* [[Metastasis]]
:* In many cases, lung cancer will spread out to other parts of the body. Some of the more common places lung cancer metastasizes to are the [[bones]], [[liver]], [[brain]], and [[adrenal glands]].
 
:* In many cases, lung cancer will spread to other parts of the [[Human body|body]]. Some of the more common places lung cancer [[Metastasis|metastasizes]] to are the [[bones]], [[liver]], [[brain]], and [[adrenal glands]].
* [[Horner's syndrome]]
* [[Horner's syndrome]]
:* Tumors in the top (apex) of the lung, known as [[Pancoast tumor]]s, may invade the local part of the [[sympathetic nervous system]], leading to changed sweating patterns and eye muscle problems (a combination known as [[Horner's syndrome]]).
 
:*[[Tumor|Tumors]] in the apex of the [[lung]], known as [[Pancoast tumor]]s, may [[Invasive (medical)|invade]] locally into the [[sympathetic nervous system]] leading to [[Horner's syndrome]].
*[[Superior vena cava syndrome]]  
*[[Superior vena cava syndrome]]  
**SVCS is a group of symptoms caused by obstruction of the superior vena cava. More than 60% of cases of superior vena cava obstruction are caused by malignant causes, typically a tumor outside the vessel compressing the vessel wall.
**[[Superior vena cava syndrome|SVCS]] is a group of [[Symptom|symptoms]] caused by [[obstruction]] of the [[superior vena cava]]. More than 60% of cases of [[superior vena cava]] [[obstruction]] are caused by [[Malignant|malignancies]], especially with a [[tumor]] outside the [[Blood vessel|vessel]] compressing the [[Blood vessel|vessel wall]].


'''Surgical Complications'''
'''Surgical Complications'''
* [[Bronchopleural fistula]]
* [[Bronchopleural fistula]]
:* It is when air leaks from a [[pneumonectomy]] bronchial stump
 
:* Approximately 2% of patients that undergo a [[pneumonectomy]] experience this
:* It is when air leaks from a [[pneumonectomy]] [[bronchial]] stump.
:* It will most commonly occur approximately 7 to 10 days after surgery
:* Approximately 2% of the [[patients]] that undergo a [[pneumonectomy]] experience this.
:* It will most commonly occur approximately 7 to 10 days after [[surgery]].
* [[Hemothorax]]
* [[Hemothorax]]
:* In most cases it occurs from [[bronchial vessels]] or lung parenchyma
 
:* It may have the [[symptoms]] of [[hypovolemia]]
:* Usually, it can be treated by [[transfusion]]
* [[Atelectasis]]
* [[Atelectasis]]
* [[Sputum]] retention
* [[Sputum]] retention


==Prognosis==
===Prognosis===
The prognosis of lung cancer is poor and it depends on the following:
The [[prognosis]] of lung cancer is poor and it depends on the following factors:
* Whether or not the tumor can be removed by surgery
* The stage of the cancer: the size of the tumor, whether the cancer has spread outside the lung
* The patient’s general health
* Whether the cancer has just been diagnosed or has recurred


'''Non–small cell lung cancer survival rate by stage'''<ref>Lung cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/prognosis-and-survival/survival-statistics/?region=ab </ref>
* Whether or not the [[tumor]] can be removed by [[surgery]]
*[[Cancer staging|Stage]] of the [[cancer]]
*[[Patient|Patient’s]] general health
* Whether the [[cancer]] has just been [[Diagnosis|diagnosed]] or has recurred
 
'''Non-small Cell Lung Cancer Survival Rate by Stage'''<ref>Lung cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/prognosis-and-survival/survival-statistics/?region=ab </ref>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 300px" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 300px" align="center"
| valign="top" |
| valign="top" |
|+
|+
! style="background: #4479BA; width: 20px;" | {{fontcolor|#FFF|Stage}}
! style="background: #4479BA; width: 20px;" |{{fontcolor|#FFF|Stage}}
! style="background: #4479BA; width: 20px;" | {{fontcolor|#FFF|5-year survival rate}}
! style="background: #4479BA; width: 20px;" |{{fontcolor|#FFF|5-year survival rate}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |IA
! style="padding: 5px 5px; background: #DCDCDC;" |IA
| style="padding: 5px 5px; background: #F5F5F5;" |49%  
! style="padding: 5px 5px; background: #F5F5F5;" |49%
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |IB
! style="padding: 5px 5px; background: #DCDCDC;" |IB
| style="padding: 5px 5px; background: #F5F5F5;" |45%
! style="padding: 5px 5px; background: #F5F5F5;" |45%
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |IIA
! style="padding: 5px 5px; background: #DCDCDC;" |IIA
| style="padding: 5px 5px; background: #F5F5F5;" |30%
! style="padding: 5px 5px; background: #F5F5F5;" |30%
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |IIB
! style="padding: 5px 5px; background: #DCDCDC;" |IIB
| style="padding: 5px 5px; background: #F5F5F5;" |31%  
! style="padding: 5px 5px; background: #F5F5F5;" |31%
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |IIIA
! style="padding: 5px 5px; background: #DCDCDC;" |IIIA
| style="padding: 5px 5px; background: #F5F5F5;" |14%
! style="padding: 5px 5px; background: #F5F5F5;" |14%
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |IIIB
! style="padding: 5px 5px; background: #DCDCDC;" |IIIB
| style="padding: 5px 5px; background: #F5F5F5;" |5%
! style="padding: 5px 5px; background: #F5F5F5;" |5%
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |IV
! style="padding: 5px 5px; background: #DCDCDC;" |IV
| style="padding: 5px 5px; background: #F5F5F5;" |1%
! style="padding: 5px 5px; background: #F5F5F5;" |1%
|}
|}


'''Small cell lung cancer survival rate'''
'''Small Cell Lung Cancer Survival Rate'''
* To view the prognosis among patients with small cell lung carcinoma, please click [[Small cell carcinoma of the lung natural history, complications and prognosis|'''Here''']]
 
* To view the [[prognosis]] among [[Patient|patients]] with small cell lung carcinoma, please click [[Small cell carcinoma of the lung natural history, complications and prognosis|'''Here''']].


==References==
==References==

Latest revision as of 19:40, 3 July 2019

Lung cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lung cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lung cancer Natural History, Complications and Prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lung cancer Natural History, Complications and Prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lung cancer Natural History, Complications and Prognosis

CDC on Lung cancer Natural History, Complications and Prognosis

Lung cancer Natural History, Complications and Prognosis in the news

Blogs on Lung cancer Natural History, Complications and Prognosis

Directions to Hospitals Treating Lung cancer

Risk calculators and risk factors for Lung cancer Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, Saarah T. Alkhairy M.D, Dildar Hussain, MBBS [2]

Overview

The majority of lung cancers present with advanced disease because the symptoms tend to occur later in the course of the disease. Patients experience non-specific symptoms such as cough, hemoptysis, dyspnea, chest pain, difficulty speaking, difficulty swallowing, lack of appetite, weight loss, and fatigue from 3 weeks to 3 months before seeking medical attention. There are a variety of complications associated with lung cancer, such as pleural effusion, leg weakness, paresthesias, bladder dysfunction, seizures, hemiplegia, cranial nerve palsies, confusion, personality changes, skeletal pain, pleuritic pain, atelectasis, and bronchopleural fistula. The prognosis of lung cancer is poor if diagnosed at the advanced stages.

Natural History, Complications, and Prognosis

Natural History

Complications

General Complications

The complications associated with lung cancer are:[2][3]

  • It is possible that lung cancer will cause pain as well, especially if it spreads to the pleura or other areas of the body, like the bones.

Surgical Complications

Prognosis

The prognosis of lung cancer is poor and it depends on the following factors:

Non-small Cell Lung Cancer Survival Rate by Stage[4]

Stage 5-year survival rate
IA 49%
IB 45%
IIA 30%
IIB 31%
IIIA 14%
IIIB 5%
IV 1%

Small Cell Lung Cancer Survival Rate

References

  1. 1.0 1.1 1.2 Leary, A (2012). Lung cancer a multidisciplinary approach. Chichester, West Sussex, UK Ames, Iowa: Wiley-Blackwell. ISBN 9781405180757.
  2. Jones, DR (Jul 1998). "Pancoast tumors of the lung". Current Opinion in Pulmonary Medicine. 4 (4): 191–197. PMID 10813231. Unknown parameter |coauthors= ignored (help)
  3. Eren S, Karaman A, Okur A (2006). "The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT". Eur J Radiol. 59 (1): 93–103. doi:10.1016/j.ejrad.2006.01.003. PMID 16476534.
  4. Lung cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/lung/prognosis-and-survival/survival-statistics/?region=ab

Template:WH Template:WS